Ledger.Open graph →
SEC Form D · filed April 17, 2013

Presidio Pharmaceuticals, Inc

Offering
$15.0M
Sold
$8.6M
Exemption
—
Industry
Pharmaceuticals
Location
SAN FRANCISCO, CA
Type
—

People & firms on this filing (21)

Nathaniel Brown · San Francisco, CAExecLeo Redmond · San Francisco, CAExec · DirectorScott Lessing · San Francisco, CADirectorEric Ruby · San Francisco, CAExecKenneth Galbraith · San Francisco, CADirectorLeping Li · San Francisco, CAExecJohn F. Obijeski · San Francisco, CADirectorH. Daniel Perez · San Francisco, CADirectorRichard Colonno · San Francisco, CAExecKelvin Neu · San Francisco, CADirectorJohn G. Barrie · EDINBURGH, SCOTLAND, United KingdomDirectorGeorge W. Browning · EDINBURGH, SCOTLAND, United KingdomExec · DirectorRon Hunt · East Providence, RIDirectorJoshua M. Braunfeld · New York, NYDirectorRobert Weiss · New York, NYExecKevin B. Cashen · Lutherville, MDExecByler Kerry · CHICAGO, ILDirectorAlan Krigstein · PHILADELPHIA, PAExecKwadwo O. Dodi · NEWARK, NJExecKelvin Neu · Newark, DEDirectorH. Thomas Anderton · San Francisco, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗